Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Abnormal Menstrual Bleeding Evaluation and Management

Definition and Prevalence

  • Heavy or prolonged bleeding is considered abnormal and may require medical evaluation, according to the Centers for Disease Control and Prevention (CDC) 2, 3

Evaluation

  • If clinically indicated, consider underlying gynecological problems when a woman presents with heavy or prolonged bleeding, as recommended by the CDC 3
  • Potential underlying conditions to evaluate include displacement of intrauterine devices 3, sexually transmitted diseases 1, pregnancy 2, and new pathologic uterine conditions (polyps or fibroids) 3
  • Laboratory tests that may be useful include complete blood count 1 and coagulation studies 3

Management

  • For women with unacceptable heavy or prolonged bleeding, NSAIDs for short-term treatment (5-7 days) may be effective, as recommended by the CDC 3, 2
  • Hormonal treatments such as low-dose combined oral contraceptives may be considered for short-term management (10-20 days) if medically eligible, according to the CDC 2
  • Tranexamic acid may reduce menstrual blood loss, though caution is needed in women with thromboembolic disease, as noted by the CDC 3

Special Considerations

  • Women should be counseled that while unscheduled bleeding is common with hormonal contraceptive use, heavy or prolonged bleeding is uncommon and warrants evaluation, as recommended by the CDC 2, 5